Canada markets open in 8 hours 42 minutes

Lobe Sciences Ltd. (LOBE.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
0.1150-0.0050 (-4.17%)
At close: 3:59PM EDT
Full screen
Previous Close0.1200
Open0.0000
Bid0.1100 x N/A
Ask0.1150 x N/A
Day's Range0.0000 - 0.0000
52 Week Range
Volume0
Avg. Volume1,085,538
Market Cap22.969M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.0430
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Lobe Sciences to Present at the Benzinga Global Small Cap Conference
    Newsfile

    Lobe Sciences to Present at the Benzinga Global Small Cap Conference

    Vancouver, British Columbia--(Newsfile Corp. - May 6, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") is pleased to announce that it will be presenting at the Benzinga Global Small Cap Conference taking place on May 13-14, 2021. Philip Young, CEO and Director will be presenting on Thursday May 13th at 12:25 pm ET.Philip Young, CEO and Director of Lobe, stated, "We look forward to discussing the latest developments and opportunities ...

  • Lobe Sciences Acquires Vitamind Line of Wellness Products
    Newsfile

    Lobe Sciences Acquires Vitamind Line of Wellness Products

    Addition of consumer packaged goods ("CPG") line of functional mushroom products further expands Lobe's operations and reach across the psychedelic space Vancouver, British Columbia--(Newsfile Corp. - May 4, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") is pleased to announce that it has acquired, through its wholly owned subsidiary Eleusian Biosciences Corp. ("Eleusian"), the consumer goods product line, "Vitamind", pursuant to an asset purchase agreement (the "Purchase Agreement") dated April 30, ...

  • Lobe Sciences Announces Filing of PCT Application
    Newsfile

    Lobe Sciences Announces Filing of PCT Application

    PCT filing further strengthens the Company's intellectual property portfolio Vancouver, British Columbia--(Newsfile Corp. - April 29, 2021) - Lobe Sciences Ltd. ("Lobe" or the "Company") (CSE: LOBE) (OTC Pink: GTSIF) is pleased to announce the filing of a key Patent Cooperation Treaty ("PCT") application entitled Methods, Compositions and Devices for Treating Mild Traumatic Brain Injury, Post Traumatic Stress Disorder and Mild Traumatic Brain Injury with Post Traumatic Stress Disorder.Philip Young, CEO and Director of Lobe ...